Clinical Trial Update: Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of oxaliplatin, gemcitabine, and erlotinib in advanced chemo-naïve pancreatic cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)
• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: National Guard Health Affairs | Conditions: Pancreatic Cancer | Phase 2 | Status: TERMINATED